End-of-day quote
Other stock markets
|
||
- | - |
Mar. 22 | HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% | MT |
Mar. 21 | HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 99.59B 72.4M 0 | Sales 2023 | 97.99B 71.24M 0 | Capitalization | 1,166B 847M 0 |
---|---|---|---|---|---|
Net income 2022 | -54.28B -39.46M - | Net income 2023 | -5.98B -4.35M - | EV / Sales 2022 | 11 x |
Net Debt 2022 | 16.03B 11.66M 0 | Net Debt 2023 | 87.72B 63.77M 0 | EV / Sales 2023 | 12.8 x |
P/E ratio 2022 |
-18.7
x | P/E ratio 2023 |
-197
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Ki-Hwan Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yoon-Gi Baek
BRD | Director/Board Member | 61 | - |
1st Jan change | Capi. | |
---|---|---|
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B |